Torrent Pharma Inc. (TPI) is the 100% US subsidiary of Torrent Pharmaceuticals Ltd, a leading pharmaceuticals company in India with a growing presence in the global generics market. TPI was set up in 2004 and currently has 64 FDA approved generic products being commercialized in the US. Several products have leading market shares between 10-30% in their respective categories, including 14 products ranked in top 3. The company expects the US business to grow as it has rich pipeline of ANDAs and is expanding its manufacturing facilities in India. TPI is an equal opportunity employer that embraces diversity in the workplace.
View Top Employees from Torrent Pharma Inc.Website | http://www.torrentpharma.com/ |
Ticker | TORNTPOWER |
Revenue | $1.06 billion |
Funding | $133.7 million |
Employees | 1,340 (750 on RocketReach) |
Founded | 1959 |
Phone | +91 79 2659 9000 |
Fax | +91 79 2658 2100 |
Industry | Pharmaceutical Manufacturing, Pharmaceuticals, Drug Discovery, Generic Pharmaceuticals, Healthcare, Drug Delivery |
Web Rank | 2 Million |
Keywords | Generic Drugs, Pharmaceutical Manufacturing, Pharmaceutical Distribution |
Competitors | CPFL Energia, Copel - Companhia Paranaense de Energia, J-POWER, Korea Electric Power Corporation (KEPCO), United Illuminating |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 32 Companies, NAICS Code 32541 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies |
Looking for a particular Torrent Pharma Inc. employee's phone or email?
The Torrent Pharma Inc. annual revenue was $1.06 billion in 2024.
Joseph Del Buono is the CFO of Torrent Pharma Inc..
750 people are employed at Torrent Pharma Inc..
The NAICS codes for Torrent Pharma Inc. are [32, 32541, 3254, 325].
The SIC codes for Torrent Pharma Inc. are [28, 283].